158 related articles for article (PubMed ID: 25667460)
1. Vitamin D effect on growth and vitamin D metabolizing enzymes in triple-negative breast cancer.
Richards SE; Weierstahl KA; Kelts JL
Anticancer Res; 2015 Feb; 35(2):805-10. PubMed ID: 25667460
[TBL] [Abstract][Full Text] [Related]
2. The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
Karaky M; Alcina A; Fedetz M; Barrionuevo C; Potenciano V; Delgado C; Izquierdo G; Matesanz F
Mult Scler; 2016 Jul; 22(8):999-1006. PubMed ID: 26466946
[TBL] [Abstract][Full Text] [Related]
3. Effect of Vitamin D on Paclitaxel Efficacy in Triple-negative Breast Cancer Cell Lines.
Wilhelm CA; Clor ZJ; Kelts JL
Anticancer Res; 2018 Sep; 38(9):5043-5048. PubMed ID: 30194148
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer.
Voutsadakis IA
Mol Biol Rep; 2020 Dec; 47(12):9821-9830. PubMed ID: 33259013
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
6. Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.
Horvath E; Lakatos P; Balla B; Kósa JP; Tóbiás B; Jozilan H; Borka K; Horváth HC; Kovalszky I; Szalay F
Anticancer Res; 2012 Nov; 32(11):4791-6. PubMed ID: 23155244
[TBL] [Abstract][Full Text] [Related]
7. Reprint of "Vitamin D deficiency in pregnant women impairs regulatory T cell function".
Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
J Steroid Biochem Mol Biol; 2015 Apr; 148():194-201. PubMed ID: 25644204
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
9. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
11. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
[TBL] [Abstract][Full Text] [Related]
12. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D--metabolism in the human breast cancer cell line MCF-7.
Diesing D; Cordes T; Fischer D; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(4A):2755-9. PubMed ID: 16886688
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.
Blomberg Jensen M; Nielsen JE; Jørgensen A; Rajpert-De Meyts E; Kristensen DM; Jørgensen N; Skakkebaek NE; Juul A; Leffers H
Hum Reprod; 2010 May; 25(5):1303-11. PubMed ID: 20172873
[TBL] [Abstract][Full Text] [Related]
15. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells.
Kloss M; Fischer D; Thill M; Friedrich M; Cordes T; Salehin D; Diedrich K; Köster F
Anticancer Res; 2010 Nov; 30(11):4429-34. PubMed ID: 21115889
[TBL] [Abstract][Full Text] [Related]
17. Expression of VDR and CYP24A1 mRNA in human tumors.
Anderson MG; Nakane M; Ruan X; Kroeger PE; Wu-Wong JR
Cancer Chemother Pharmacol; 2006 Jan; 57(2):234-40. PubMed ID: 16180015
[TBL] [Abstract][Full Text] [Related]
18. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
[TBL] [Abstract][Full Text] [Related]
19. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.
Lechner D; Kállay E; Cross HS
Mol Cell Endocrinol; 2007 Jan; 263(1-2):55-64. PubMed ID: 17029768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
